Bender, L., Kurtz, J., Petit, T., & Pivot, X. (2020). Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size. International journal of breast cancer, 23(6), 672-673. https://doi.org/10.4048/jbc.2020.23.e62
Citace podle Chicago (17th ed.)Bender, Laura, Jean-Emmanuel Kurtz, Thierry Petit, a Xavier Pivot. "Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size." International Journal of Breast Cancer 23, no. 6 (2020): 672-673. https://doi.org/10.4048/jbc.2020.23.e62.
Citace podle MLA (9th ed.)Bender, Laura, et al. "Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size." International Journal of Breast Cancer, vol. 23, no. 6, 2020, pp. 672-673, https://doi.org/10.4048/jbc.2020.23.e62.